Skip to main content
Caplight Logo









Plurify

Plurify

Private
CambridgeHealthcare & Life Scienceshttps://plurify.bio/

Last Round

Grant

Jun 19, 2024

Total Funding Raised

$430,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Plurify is a biotechnology company that has developed a scalable molecular purification platform designed to eliminate unwanted cells during the manufacturing of stem cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

cell purificationin-bioreactor purificationcell therapy manufacturingRNA platformstem cell therapyprogrammable RNAcell therapy safetyCGT manufacturingbiomanufacturingprocess intensificationcontract manufacturing organizationsCMOsgene therapy manufacturingCMC toolsAAV vector productionbioinformatics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Plurify Comparables

Compare Plurify with similar companies based on industry and business-model similarity.

Plurify comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mogrify
63%
TreeFrog Therapeutics
63%
Miltenyi Biotec
62%

Plurify Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 19, 2024
AcceleratorMay 1, 2024
SeedJan 5, 2024

Key People

Founding team and executive leadership

Mantas Matjusaitis

Co-Founder & CTO

Founding Team

Chris Monk

COO

Executive Team

Plurify Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 508% MoM, from 485 to 2.9K.

  • Jul 20, 2026

    Open roles increased to 4, representing 44% of headcount.

Plurify Filings

Explore SEC and related filing metadata, where available.

Plurify filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Plurify's valuation, stock price, and market status.

Is Plurify a public or private company?

Plurify is a private company.

What is the current stock price of Plurify?

Plurify is a private company with no public stock price. No recent secondary market data is available.

How much is Plurify worth (valuation)?

Valuation information for Plurify is not publicly available.

Can I buy Plurify stock?

Plurify shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Plurify's last funding round?

Funding round information for Plurify is not publicly available.

Who are the main investors in Plurify?

Investor information for Plurify is not publicly disclosed.

Will Plurify IPO soon?

No public IPO plans have been announced for Plurify.

How can I track Plurify secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Plurify's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range8
Year Founded2023
Last FundingJun 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?